1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. North Carolina >
  6. Xcovery Acquires Meryx

M&A Deal Summary

Xcovery Acquires Meryx

On December 7, 2021, Xcovery acquired life science company Meryx

Acquisition Highlights
  • This is Xcovery’s 1st transaction in the Life Science sector.
  • This is Xcovery’s 1st transaction in the United States.
  • This is Xcovery’s 1st transaction in North Carolina.

M&A Deal Summary
Date 2021-12-07
Target Meryx
Sector Life Science
Buyer(s) Xcovery
Deal Type Add-on Acquisition

Target

Meryx

Chapel Hill, North Carolina, United States
Meryx is a clinical stage immuno-oncology company focused on advancing small molecule, orally bioavailable inhibitors of Mer Receptor Tyrosine Kinase (RTK) that inhibit growth and initiate anti-tumor immunity in a range of hematologic and solid malignancies. Meryx is based in Chapel Hill, North Carolina.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Xcovery

Palm Beach Gardens, Florida, United States
Category Company
Founded 2006
Sector Life Science
DESCRIPTION

Xcovery is a biopharmaceutical company working to improve the lives of patients with cancer by discovering and developing small molecules that precisely target cancer growth mechanisms. Xcovery was founded in 2006 and is based in Palm Beach Gardens, Florida.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: North Carolina M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2021 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal